With slight heterogeneity (P = 0.055, I2 = 53.8%), a random-effects model showed increased nestin expression in patients with breast cancer predicted reduced OS (pooled HR = 1.88, 95% CI [1.31, 2.71], P = 0.0007) (Fig. 2e). This evidence concerns the gene NES and breast carcinoma.